Statistical modelling of the formulation variables in non-viral gene delivery systems

被引:6
作者
Birchall, JC
Waterworth, CA
Luscombe, C
Parkins, DA
Gumbleton, M
机构
[1] Glaxo Wellcome PLC, Pharmaceut Res & Dev, Ware SG12 0DP, Herts, England
[2] Cardiff Univ, Welsh Sch Pharm, Cardiff CF10 3XF, S Glam, Wales
关键词
central composite design; gene delivery; in vitro transfection; modelling; multifactorial analysis;
D O I
10.3109/10611860108997926
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Traditionally, optimisation of a gene delivery formulation utilises a study design that involves altering only one formulation variable at any one time whilst keeping the other variables constant. As gene delivery formulations become more complex, e.g. to include multiple cellular and sub-cellular targeting elements, there will be an increasing requirement to generate and analyse data more efficiently and allow examination of the interaction between variables. This study aims to demonstrate the utility of multifactorial design, specifically a Central Composite Design, in modelling the responses size, zeta potential and in vitro transfection efficiency of some prototypic non-viral gene delivery vectors, i.e. cationic liposome-pDNA complexes, and extending the application of the design strategy to more complex vectors, i.e. tri-component lipid:polycation:DNA (LPD). The modelled predictions of how the above responses change as a function of formulation show consistency with an extensive literature base of data obtained using more traditional approaches, and highlight the robustness and utility of the Central Composite Design in examining key formulation variables in non-viral gene delivery systems. The approach should be further developed to maximise the predictive impact of data across the full range of pharmaceutical sciences.
引用
收藏
页码:169 / 184
页数:16
相关论文
共 22 条
[1]   Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration [J].
Anchordoquy, TJ ;
Carpenter, JF ;
Kroll, DJ .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1997, 348 (01) :199-206
[2]   Experimental designs in the optimisation of ultrasonic bath-acid-leaching procedures for the determination of trace elements in human hair samples by atomic absorption spectrometry [J].
Bermejo-Barrera, P ;
Muñiz-Naveiro, O ;
Moreda-Piñeiro, A ;
Bermejo-Barrera, A .
FORENSIC SCIENCE INTERNATIONAL, 2000, 107 (1-3) :105-120
[3]   Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes [J].
Birchall, JC ;
Kellaway, IW ;
Mills, SN .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 183 (02) :195-207
[4]   Physical stability and in-vitro gene expression efficiency of nebulised lipid-peptide-DNA complexes [J].
Birchall, JC ;
Kellaway, IW ;
Gumbleton, M .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 197 (1-2) :221-231
[5]   Experimental design in supercritical fluid extraction of cocaine from coca leaves [J].
Brachet, A ;
Christen, P ;
Gauvrit, JY ;
Longeray, R ;
Lantéri, P ;
Veuthey, JL .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 2000, 43 (1-3) :353-366
[6]   A central composite design to investigate the thermal stabilization of lysozyme [J].
Branchu, S ;
Forbes, RT ;
York, P ;
Nyqvist, H .
PHARMACEUTICAL RESEARCH, 1999, 16 (05) :702-708
[7]  
Crook K, 1996, GENE THER, V3, P834
[8]  
FARHOOD H, 1994, BIOCHIM BIOPHYS ACTA, V1189, P195
[9]   Potentiation of cationic liposome-mediated gene delivery by polycations [J].
Gao, X ;
Huang, L .
BIOCHEMISTRY, 1996, 35 (03) :1027-1036
[10]   Formulation design and optimization of modified-release microspheres of diclofenac sodium [J].
Gohel, MC ;
Amin, AF .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (02) :247-251